Nivolumab-associated nausea and vomiting as an immune adverse event. European journal of cancer (Oxford, England : 1990) Shi, Y. n., Lin, P. n., Ho, E. Y., Nock, C. J. 2017; 84: 367–69

View details for DOI 10.1016/j.ejca.2017.07.029

View details for PubMedID 28827043